Of note, pharmacological inhibition of CRM1 using LMB rescued the senescence phenotype of HGPS cells (García‐Aguirre et al. 2019), highlighting the pivotal role of the nuclear export mechanisms in HGPS pathogenesis and pointing at CRM1 as a potential target for therapeutic intervention. This evidence concerns the gene XPO1 and Hutchinson-Gilford progeria syndrome.